Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BI 187004 Monotherapy and Add-on to Metformin in Type 2 Diabetes
NCT02150824Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2014
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BI 187004 in type 2 diabetes mellitus (T2DM), sponsored by Boehringer Ingelheim. Started Jul 2014; status: completed.
02
Drugs
BI 187004
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02150824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02150824.